Kidney Diseases
287
37
61
143
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
31 trials with published results (11%)
Research Maturity
143 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.6%
19 terminated out of 287 trials
88.3%
+1.7% vs benchmark
16%
45 trials in Phase 3/4
22%
31 of 143 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 143 completed trials
Clinical Trials (287)
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
Promoting Increases in Living Donation Via Tele-navigation (PILOT)
NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities
Recontrast and Renal Outcomes in Patients With Pre-Existing Renal Dysfunction
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Savolitinib vs. Sunitinib in MET-driven PRCC.
TESTING -ON Post-Trial ObservatioNal Cohort Study
Access to Kidney Transplantation in Minority Populations
Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic Disorders
Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney Disease
Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients - <BELAFENDO>
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
HOLT-ED: Holter-monitoring in End-stage Renal Disease
Home-based Interventions for FrAilty preveNTion in AdultS With DIabeTes and Chronic Kidney Disease
Mechanisms of Diabetic Nephropathy in Ecuador
Proteomic Analysis of Amniotic Fluid to Predict Postnatal Renal Function in Fetuses With Renal and Urinary Tract Malformations
Supporting VETerans With Kidney Disease Through Food As Medicine